WindRose Health Investors Closes Oversubscribed Fund VII at $2.6 Billion

WindRose健康投资者以26亿美元超额认购关闭第七基金

NEW YORK, December 3, 2025-- New York-based healthcare private equity firm WindRose Health Investors, LLC ('WindRose') announced that it has closed its seventh fund, WindRose Health Investors VII, L.P. ('Fund VII') with $2.6 billion in limited partner and general partner commitments. The fund closed at its hard cap and significantly exceeded the size of Fund VI, its $1.4 billion predecessor fund..

纽约，2025年12月3日——总部位于纽约的医疗保健私募股权公司WindRose Health Investors, LLC（“WindRose”）宣布，其第七只基金WindRose Health Investors VII, L.P.（“基金七”）已完成募集，有限合伙人和普通合伙人承诺出资额达26亿美元。该基金在其硬性上限完成募集，并且规模显著超过了其前一只基金——募资14亿美元的第六只基金。

Oliver T. Moses, WindRose's Managing Partner, said, 'We are deeply grateful for the ongoing support of our existing investors as well as the confidence placed in us by a world-class group of new investors across the Americas, Europe, the Middle East and Asia. As a result of their trust, we were able to close Fund VII in just six months.

奥利弗·T·摩西斯，WindRose的管理合伙人表示：“我们深深感谢现有投资者的持续支持，以及来自美洲、欧洲、中东和亚洲的一流新投资者群体对我们的信任。由于他们的信赖，我们仅用六个月就成功完成了第七期基金的募集。”

We are now eager to get to work on our latest fund and are optimistic about continued opportunities to invest in innovative, tech-enabled businesses that are improving quality and enhancing efficiency in healthcare.' .

我们渴望在我们的最新基金上开始工作，并对继续投资于创新的、技术驱动的、改善医疗保健质量和提高效率的企业感到乐观。

Fund VII, which expects to close on its first two acquisitions by year-end 2025, attracted a diverse mix of institutional investors, including pensions, insurance companies, financial institutions, foundations, funds-of-funds, and family offices. The fund is targeting 11-13 investments in total.

基金七预计将在2025年底前完成其前两笔收购，吸引了包括养老基金、保险公司、金融机构、基金会、母基金和家族办公室在内的多元化机构投资者。该基金总共计划进行11至13项投资。

'We appreciate our investors' continued confidence, especially in a challenging fundraising environment,' added Catherine Coleman, WindRose's Head of Investor Relations. 'WindRose believes that it has developed a set of value creation capabilities that is built for the direction of the healthcare industry and gives our portfolio companies a significant competitive advantage in the race to innovate and grow.' .

“我们感谢投资者持续的信任，尤其是在充满挑战的募资环境中，”WindRose投资者关系主管凯瑟琳·科尔曼补充道。“WindRose相信，公司已经建立了一套为医疗行业发展方向量身打造的价值创造能力，这将使我们的投资组合公司在创新和增长的竞争中具备显著优势。”

Evercore Private Funds Group acted as WindRose's exclusive global placement agent and Kirkland & Ellis LLP served as fund counsel.

Evercore私人基金集团担任WindRose的独家全球配售代理，Kirkland & Ellis LLP担任基金法律顾问。

About WindRose Health Investors

关于风向标健康投资者

New York City-based WindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. With approximately $7 billion under management, WindRose invests in companies throughout the United States.

总部位于纽约市的 WindRose 对医疗保健行业服务领域内的公司进行股权投资。该机构专注于拥有盈利商业模式并具备提供高性价比解决方案能力的公司。WindRose 管理着约 70 亿美元的资金，投资于全美各地的公司。

For more information, please email us at info@windrose.com..

有关更多信息，请通过 info@windrose.com 与我们联系。

Contact:

联系人：

Lambert by LLYC

兰伯特 by LLYC

Caroline Luz

卡罗琳·卢兹

203-570-6462

203-570-6462

cluz@lambert.com

cluz@lambert.com